CA 15-3 as a tumor marker in gynecological malignancies

Giovanni Scambia, G Scambia, P Benedetti Panici, G Baiocchi, L Perrone, S Greggi, Stefano Greggi, S Mancuso, Stefano Mancuso
Gynecologic oncology · 1988 · vol. 30(2) , pp. 265–273 · doi:10.1016/0090-8258(88)90032-7 · PMID:3163666 · W2016682363
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This review analyzes the utility and limitations of CA 15-3 as a tumor marker across various gynecological cancers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Antigens, Neoplasm Biomarkers, Tumor Genital Neoplasms, Female Adolescent Adult Antibodies, Monoclonal Antigens, Neoplasm Antigens, Tumor-Associated, Carbohydrate Biomarkers, Tumor Female Genital Neoplasms, Female Genital Neoplasms, Female Genital Neoplasms, Female Humans Membrane Glycoproteins Membrane Glycoproteins Middle Aged Mucin-1 Neoplasm Staging Postoperative Period

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (25)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:09:20.810540+00:00
License: CC0 · commercial use OK